53.22  0.3 (0.57%)		05-10 16:00
Open: 56.1 High: 56.1 Volume: 211,163		Pre. Close: 52.92 Low: 51.3 Market Cap: 3,002(M)

Short term
Mid term
Targets	6-month :	67.95	1-year :	79.37
Resists	First :	58.18	Second :	67.95
Pivot price	50.56
Supports	First :	49.17	Second :	43.6
MAs	MA(5) :	52.78	MA(20) :	50.44
	MA(100) :	44.93	MA(250) :	0
MACD	MACD :	-0.6	Signal :	-1.2
%K %D	K(14,3) :	73.9	D(3) :	74.5
RSI	RSI(14): 51.5
52-week	High :	72.29	Low :	14.18

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ APGE ] has closed below upper band by 24.6%. Bollinger Bands are 30.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	56.15 - 56.37	56.37 - 56.62
Low:	50.75 - 50.97	50.97 - 51.22
Close:	52.8 - 53.16	53.16 - 53.57

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.

Sun, 12 May 2024
Apogee Therapeutics (NASDAQ:APGE) Research Coverage Started at Bank of America - Defense World

Sun, 12 May 2024
Apogee Therapeutics (NASDAQ:APGE) Shares Gap Up to $52.92 - Defense World

Sat, 11 May 2024
Apogee Therapeutics (NASDAQ:APGE) Shares Gap Up to $52.92 - MarketBeat

Sat, 11 May 2024
B of A Securities Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation - MSN

Mon, 06 May 2024
Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference - Marketscreener.com

Mon, 06 May 2024
Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	43 (M)
Shares Float	31 (M)
Held by Insiders	11.8 (%)
Held by Institutions	100.9 (%)
Shares Short	4,550 (K)
Shares Short P.Month	3,050 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	7.5
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-21 %
Return on Equity (ttm)	-32.2 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-75 (M)
Levered Free Cash Flow	-46 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	7.09
Price to Sales	0
Price to Cash Flow	-30.56

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.